Bladder cancer

• The impact of PDD during TURB for NMIBC: a prospective randomized controlled trial Pending
  2024-514316-27-00 6 "Not muscular invasive bladder cancer"
• Bladder Preservation with Sacituzumab Govitecan + Zimberelimab for MuscleInvasive Bladder cancer in cisplatin-unfit and unwilling for cystec … Pending
  2024-516943-14-01 4 "Muscle-Invasive Bladder cancer"
• A Phase III study evaluating the efficacy of atezoliumab administration in addition to BCG (Bacillus Calmette-Guerin) for 1 year in patient … Pending
  2024-517621-54-00 5 "High-risk non-muscle invasive bladder cancer (NMIBC) after t"
• A trial to learn how safe durvalumab with chemotherapy is and how well it works in adults with muscle-invasive bladder cancer Pending
  2024-519246-75-01 4 "Patients With Muscle-Invasive Bladder Cancer"
• A clinical trial of sacituzumab tirumotecan to treat urothelial cancer (MK-2870-031) Recruiting
  2024-520014-22-00 5 2026-04-22 "Locally advanced/metastatic urothelial carcinoma"
• A Phase 1a/1b, Open-Label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity … Recruiting
  2025-523165-19-00 1 2026-02-10 "Advanced, metastatic or unresectable solid tumors"
• A Phase 1/2, Multicenter, Open Label, Dose Escalation and Dose Expansion Study of JK06, a 5T4 Antibody Drug Conjugate, in Patients with Unre … Recruiting
  2024-512421-92-00 7 2025-10-14 "Unresectable, Locally Advanced or Metastatic Cancer"
• A Phase 1 Open-label Study to Evaluate the Safety and Efficacy of MK‑8294 Monotherapy in Advanced Solid Tumors Recruiting
  2024-516870-31-00 1 2025-07-11 "Endometrial Carcinoma"
• A clinical study of V940 and BCG in people with bladder cancer (V940-011) Recruiting
  2024-517335-46-00 4 2025-06-05
• A study to learn more about how well treatment with sevabertinib (BAY2927088) tablets works and how safe it is in participants who have a so … Recruiting
  2024-517419-62-00 4 2025-02-28 "HER2 mutation"
• A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients With BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) an … Recruiting
  2024-512900-20-00 7 2025-01-30 "Non-muscle invasive bladder cancer (NMIBC)"
• The Effect of Cancer Treatments on Speech Perception in Noise, Cognition, and Quality of Life Recruiting
  2024-513437-21-00 6 2024-10-02 "Cancer"
• Study of AZD9574 as monotherapy and in combination with anti-cancer agents in patients with advanced solid malignancies Recruiting
  2023-504984-17-00 7 2022-10-05 "Module 3: advanced/relapsed HER2-negative breast, ovarian, p"
• A Study of Sigvotatug Vedotin in Advanced Solid Tumors Recruiting
  2023-508469-34-00 1 2020-10-14 "Esophageal cancer"
• A Phase 3 Single-arm Study of UGN-103 for the Treatment of LG IR NMIBC. Recruitment ended
  2023-507261-25-00 5 2024-10-03 "Nonmuscle Invasive Bladder Cancer"
• A Phase 3, Randomized, Open-label, Multi-center Study Evaluating the Efficacy and Safety of TAR-200 Versus Investigator’s Choice of Intraves … Recruitment ended
  2023-507685-10-00 5 2024-05-30 "High-Risk Non-muscle-invasive Bladder Cancer"
• A Phase 2, open-label, multi-centre, multi-national interventional trial to evaluate the efficacy and safety of erdafitinib (ERDA) monothera … Recruitment ended
  2024-512573-27-01 4 2023-12-11 "Muscle-invasive bladder cancer (MIBC)"
• A multi-center Phase 2 study of neoadjuvant immunotherapy in combination with the anti-GDF-15 antibody visugromab (CTL-002) for the treatmen … Recruitment ended
  2024-513957-55-00 4 2023-07-21 "Muscle invasive bladder cancer set to undergo radical cystec"
• A phase II prospective, open-label, multi-centre, single arm study of sasanlimab plus sacituzumab govitecan in BCG (Bacillus Calmette-Guérin … Recruitment ended
  2024-518486-10-00 4 2023-02-23 "Non-Muscle Invasive Bladder Cancer"
• A Phase 3 Single-Arm Study of UGN-102 for Treatment of LG IR NMIBC Recruitment ended
  2023-506680-34-00 5 2022-03-24 "Non-Muscle Invasive Bladder Cancer"
• A trial to learn how well durvalumab and chemotherapy with or without tremelimumab work in adults with advanced cancer of the bladder or uri … Recruitment ended
  2024-510976-19-00 5 2018-11-30 "Patients with Unresectable Locally Advanced or Metastatic Ur"
• A dose-escalation and expansion study of the safety and pharmacokinetics of XB002 as single-agent and combination therapy in subjects with i … Ended
  2023-508267-69-00 3 2023-08-11 "Subjects with Aadvanced solid tumors for whom life-prolongin"
• A study to test whether BI 907828 helps people with cancer in the biliary tract, pancreas, lung, or bladder Ended
  2023-506369-79-00 4 2022-11-30 "Pancreatic ductal adenocarcinoma"
• A PHASE 1/2, OPEN-LABEL, MULTICENTER STUDY TO INVESTIGATE THE SAFETY, PHARMACOKINETICS AND EFFICACY OF CYC140, AN ORAL PLK1 INHIBITOR, IN SU … Ended
  2024-516290-67-00 9 2022-08-03 "ADVANCED SOLID TUMORS AND LYMPHOMA"

Showing 1–24 of 29 trials